PPP1CB / Serine/threonine-protein phosphatase PP1-beta catalytic subunit · Western blot design guide

Design a Western Blot for PPP1CB

Source-linked PPP1CB Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PPP1CB WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for PPP1CB: expected band ~37.2 kDa, hero antibody M04022-1, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable PPP1CB Western blot protocol sheet — expected band ~37.2 kDa, antibody M04022-1, controls and PMC citations. Open the full PPP1CB WB guide →

PPP1CB Western Blot Experimental Design Guide

Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~37.2 kDa
Gel 12–15% (standard starting point)
Positive control ⓘ Appendix (IHC candidate; verify WB) +4 more
Negative control ⓘ Adipose tissue (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM Phosphorylated + Acetylated
Caveat Modification-state controls
Gene-set association MSigDB C7 membership
Isoform 1 isoform(s)
Section 1

Source-Linked PPP1CB Western Blot Protocol Options

The M04022-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysateJurkat cell lysate (catalog M04022-1)
Gel %12–15% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferStandard semi-dry transfer; verify efficiency (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyM04022-1; use the WB datasheet starting dilution (standard starting point)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected PPP1CB Western Blot Band Size?

PPP1CB is predicted at 37.2 kDa; its annotated modifications could affect migration, but no empirical band or visible shift is established.

What am I looking at on my blot?
Single band near 37.2 kDaConsistent with full-length PPP1CB; confirm identity with a specific control
Band near 37.2 kDa in cytoplasmic fractionConsistent with its documented cytoplasmic localization
Band near 37.2 kDa in nuclear fractionConsistent with its documented nuclear localization
Possible close doublet near 37.2 kDaThr316 phosphorylation could affect migration, but a doublet is not established
💡Expected PPP1CB appearanceUniProt predicts 37.2 kDa for PPP1CB; no empirical band size is supplied, so confirm a band near that mass with an identity control.
How each factor affects band size
UniProt predicted massPlaces the full-length protein near 37.2 kDa
327-residue sequenceDefines the full-length protein underlying the 37.2 kDa prediction
N-acetylalanine at residue 2Is annotated, with no demonstrated visible size shift
Phosphothreonine at residue 316Could affect migration, but no band shift is demonstrated
Why is my band missing or off?
SituationLikely causeNext action
No band in lysatePPP1CB can occur in cytoplasmic and nuclear compartmentsCheck both fractions and a suitable positive lysate
Band higher than expectedIts identity or migration is uncertain; no glycosylation or disulfide-linked dimer is annotatedConfirm identity with PPP1CB depletion or a second antibody
Band lower than expectedIts identity is uncertain; no signal peptide or propeptide cleavage is annotatedConfirm identity with PPP1CB depletion or a second antibody
Multiple bandsThr316 phosphorylation could contribute, but distinct bands are not establishedCompare phosphatase-treated samples and confirm band identity
Weak or no signalPPP1CB may be distributed between cytoplasmic and nuclear compartmentsCheck fraction recovery and a suitable positive lysate

Sample controls for PPP1CB Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for PPP1CB in Western blot, you can use appendix tissue, which HPA rates as highly expressed.
Positive control: Appendix (IHC candidate; verify WB)
Negative control: Adipose tissue (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: PPP1CB is intracellular, and HPA lists not-detected tissues that can serve as negative controls.

HPA tissue expression evidence for PPP1CB

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Appendix endocrine cells High Protein (IHC) HPA →
Gallbladder glandular cells High Protein (IHC) HPA →
Rectum endocrine cells High Protein (IHC) HPA →
Small intestine endocrine cells High Protein (IHC) HPA →
Breast glandular cells Medium Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Adipose tissue adipocytes Not detected Protein (IHC) HPA →
Hippocampus glial cells Not detected Protein (IHC) HPA →
Parathyroid gland glandular cells Not detected Protein (IHC) HPA →
Skeletal muscle myocytes Not detected Protein (IHC) HPA →
Spleen cells in red pulp Not detected Protein (IHC) HPA →
Section 3

Advanced PPP1CB Western Blot Tips

Deeper troubleshooting and optimisation questions for PPP1CB, answered from its protein features.

What should be checked when unexpected PPP1CB bands appear?
Band shift · The supplied features list no glycosylation sites, signal peptide, propeptide, or alternative sequence. They do not establish a cause for extra bands. Confirm band identity, especially because PP1 also has PPP1CA and PPP1CC catalytic subunits.
Could a second band be a PPP1CB isoform?
Isoforms · The supplied record lists one isoform and no alternative sequence. It provides no isoform-based explanation for a second band; verify band identity before assigning one.
Can PPP1CB modifications explain a shifted band?
PTM · UniProt lists N-acetylalanine at position 2 and phosphothreonine at position 316. These are UniProt coordinates; antibody or paper numbering may differ. Their presence alone does not establish a visible shift or explain a difference from 37.2 kDa.

PPP1CB has a listed phosphothreonine at UniProt position 316. A band at a different apparent mass is not, by itself, evidence of phosphorylation at that site.
Does this guide establish induction of PPP1CB?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for PPP1CB?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the M04022-1 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should PPP1CB bands be quantified across fractions?
Quantitation · PPP1CB occurs in both cytoplasmic and nuclear compartments and can relocalize. Quantify the same identified band consistently within each fraction; a change in one fraction alone need not represent a change in total cellular PPP1CB.
Should PPP1CB migrate at its predicted 37.2 kDa?
Interpretation · 37.2 kDa is the predicted mass, and no observed band position is supplied. Use it as a reference, but do not assign a band from apparent mass alone.

PPP1CB is reported in cytoplasm and nucleus, including nucleoplasm and nucleolus. It is highly mobile and can relocalize through targeting-subunit interactions, so interpret a fraction-specific signal in the context of the fraction examined.
Boster reagents

PPP1CB Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of Protein Phosphatase 1 beta expression in Jurkat cell lysate.
Anti-Protein Phosphatase 1 beta Rabbit Monoclonal Antibody
Cat # M04022-1
Real WB data Western Blot analysis using PP1β Monoclonal Antibody against Mouse brain, F9, MCF7 cell lysate.
Anti-PP1 beta PPP1CB Monoclonal Antibody
Cat # A04022-1

Two the supplier monoclonal anti-PPP1CB antibodies have WB images: M04022-1 in Jurkat lysate and A04022-1 in mouse brain, F9, and MCF7 lysates. These examples do not establish WB performance across every listed reactive species.

Which to pick: Choose M04022-1 for a Jurkat lysate precedent, or A04022-1 for a mouse brain, F9, or MCF7 lysate precedent. A04022-1 lists broader species reactivity, but the supplied WB image does not demonstrate every listed species.

Source: BosterBio PPP1CB gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.